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Abstract
The nonvirion (NV) protein of infectious hematopoietic necrosis virus (IHNV) has been previously reported to be essential for
efficient growth and pathogenicity of IHNV. However, little is known about the mechanism by which the NV supports the
viral growth. In this study, cellular localization of NV and its role in IHNV growth in host cells was investigated. Through
transient transfection in RTG-2 cells of NV fused to green fluorescent protein (GFP), a nuclear localization of NV was
demonstrated. Deletion analyses showed that the
32EGDL
35 residues were essential for nuclear localization of NV protein,
and fusion of these 4 amino acids to GFP directed its transport to the nucleus. We generated a recombinant IHNV, rIHNV-
NV-DEGDL in which the
32EGDL
35 was deleted from the NV. rIHNVs with wild-type NV (rIHNV-NV) or with the NV gene
replaced with GFP (rIHNV-DNV-GFP) were used as controls. RTG-2 cells infected with rIHNV-DNV-GFP and rIHNV-NV-DEGDL
yielded 12- and 5-fold less infectious virion, respectively, than wild type rIHNV-infected cells at 48 h post-infection (p.i.).
While treatment with poly I:C at 24 h p.i. did not inhibit replication of wild-type rIHNVs, replication rates of rIHNV-DNV-GFP
and rIHNV-NV-DEGDL were inhibited by poly I:C. In addition, both rIHNV-DNV and rIHNV-NV-DEGDL induced higher levels of
expressions of both IFN1 and Mx1 than wild-type rIHNV. These data suggest that the IHNV NV may support the growth of
IHNV through inhibition of the INF system and the amino acid residues of
32EGDL
35 responsible for nuclear localization are
important for the inhibitory activity of NV.
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Introduction
Infectious hematopoietic necrosis virus (IHNV) is a rhabdovirus
belonging to the genus Novirhabdovirus of the Rhabdoviridae family.
IHNV causes an acute disease in wild and hatchery-reared
salmonid fish in North America, Europe, and Asia [1,2]. Similar
to other rhabdoviruses, the IHNV genome encodes five structu-
ral proteins that make up the virions: a nucleoproetin (N), a
polymerase-associated phosphoprotein (P), a matrix protein (M), a
unique glycoprotein (G), and a RNA polymerase protein (L) [3,4].
The Novirhabdovirus genome possesses an additional non-virion
(NV) gene located between the viral glycoprotein (G) and the
polymerase (L) genes [3]. While the functions of most IHNV
proteins are known, that of the NV protein remains unclear.
Recently, Biacchesi et al [5] demonstrated that a recombinant
IHNV (rIHNV) knockout with no NV gene was severely impaired
for growth in cell culture and had reduced pathogenicity in
rainbow trout [6], suggesting a crucial role of NV for optimal
IHNV replication. However, the molecular basis for the role of
NV is not known.
Virus-infected cells synthesize and secrete type I interferons
(IFNs) which are considered the first line of host defense against
viral infection [7,8]. Secreted IFNs stimulate susceptible cells
to express more than 300 IFN-stimulated genes (ISGs), whose
concerted action leads to limiting further viral growth and spread
[8]. The myxovirus resistance gene Mx, the PKR protein kinase
stimulated by dsRNA, and the 29-59 oligoadenylate synthetase
(OAS) are among the best-characterized antiviral ISGs [9]. The
IFN system has also been found in teleost fish including Atlantic
salmon and rainbow trout. Teleost fish IFNs can induce the
expressions of several ISGs with antiviral activity [10,11]. The IFN
system induced by poly I:C treatment [12,13] limited the growth
of IHNV in cell culture [14] and recombinant IFN treatment
protected rainbow trout from IHNV infection [15], suggesting that
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publish,  or  preparation of the manuscript.IHNV replication is highly sensitive to the IFN-induced antiviral
responses of host cells.
It is now evident that most viruses have evolved means to down-
regulate IFN responses. In many cases they use nonstructural viral
proteins for that purpose. A good example is the nonstructural
protein NS1 of the influenza A virus. NS1 binds to RIG-I/IPS-1
complexes [16,17,18] and blocks downstream signaling [19,20,21],
resulting in attenuation of type I IFN and inflammatory cytokine
expression. These anti-interferon activities of NS1 are possible due
to a complex regulation of NS1 cellular localization mediated by
two nuclear localization signals (NLSs) and one nuclear export
signal (NES), which allow the transport of this protein between the
cytoplasm and nucleus of the infected cell [22,23]. Rhabdoviruses
also have the ability to limit IFN production and IFN signaling
[24]. However, they have been reported to use structural proteins
for this purpose. In mammalian rhabdoviruses, the M protein of
vesicular stomatitis virus (VSV) and the P protein of rabies virus
(RV) have been shown to inhibit host IFN-mediated responses
using different molecular mechanisms [25,26,27,28,29,30,31,32,
33,34,35]. However, until now, it is not known how IHNV
interacts with the host IFN system.
In this study, we showed that the 111-amino acid (aa) NV
protein of IHNV can localize to the nucleus, and identified amino
acid residues,
32EGDL
35, within the NV protein that are re-
sponsible for the nuclear localization of the NV protein. We then
investigated the roles of the NV protein and the
32EGDL
35
residues in IHNV growth using a series of various recombinant
IHNV. Collectively, our data suggest that the NV can support the
growth of IHNV in host cells through inhibition of the induction of
IFN systems, and that the amino acid sequence
32EGDL
35,
responsible for nuclear localization of the NV, plays important role
in the inhibitory activity of NV.
Methods
Cells and viruses
CHSE-214 (chinook salmon embryo) (ATCC CRL-1681), RTG-
2 (rainbow trout gonad) (ATCC CCL-55), and EPC (epithelioma
papulosum cyprini) (ATCC CRL-2872) cells were grown at 18uCi n
Eagle’s minimal essential medium (MEM) supplemented with 10%
fetal bovine serum (FBS). The transgenic cell line, RTG-P1 [36],
was purchased from ATCC (CRL-2829) and was cultivated in
Eagle’s MEM supplemented with 10% FBS and 200 mg/ml
Neomycin (G418, Sigma, St. Louis, MO). The IHNV-PRT strain
used in this study is a 1991 isolate from rainbow trout Pyongchang
Korea [37] at passage level 35. The virus was propagated in EPC
cells at 16uC and quantified in terms of plaque forming units (PFU/
ml) using the standard plaque assay [38].
Effect of poly I:C on IHNV growth
To determine the effect of pretreatment of cells with poly I:C on
the growth of IHNV, 25 cm
2 culture flasks of RTG-2 cells were
inoculated with poly I:C (final concentration 25 mg/ml) (P1530,
Sigma) and incubated for 24 h. The medium was removed and
replaced with fresh medium without poly I:C, and the cells were
challenged with IHNV at an MOI of 0.01 PFU/cell. Samples of
the supernatant were collected at 0, 24, and 48 h after virus
infection and were stored at 280uC until use.
To assess the effect of poly I:C treatment after viral infection,
RTG-2 cells were challenged with IHNV at an MOI of 0.01 and
were incubated for 24 h at 16uC. The medium was removed and
replaced with fresh medium with or without poly I:C (25 mg/ml).
Supernatant samples were collected at 0, 24, and 48 h after poly
I:C treatment and were stored at 280uC until use.
Plasmids expressing NV and transfections
The full-length cDNA of NV was amplified using RT-PCR
from the RNA of CHSE-214 cells infected with IHNV-PRT using
PCR primers as follows: pcDNA-NV: 59-GGATCCATGGAC-
CACCGCGAAACAAAC-39,5 9-CTCGAGTCTGGGATAAG-
CAAGAAA-39; pEGFP-NV: 59-GCTAGCATGGACCACCGC-
GAAACAAAC-39,5 9-GGATCCAATCTGGGATAAGCAAGA-
AA-39. The PCR products were subcloned into the BamHI/XhoI
site of pcDNA6/V5 (Invitrogen, Carsbad, USA) or NheI/BamHI
site of pEGFP-N1 (Clontech, Mountain View, CA) to create
pcDNA6/V5-NVPRT and pEGFP/NV(1–111), respectively.
A variety of deletion mutants of NV were PCR amplified using
pEGFP/NV(1–111) as a template with the following primer pairs:
NV(1–37): 59-GCTAGCATGGACCACCGCGAAACAAAC-39,
59-GGATCCAAGCCCCATACCAGGTCTCC-39; NV(38–73):
59-GCTAGCATGTGTGAAGAGGACGACGCA-39,5 9-GGAT-
CCAACTTGGTGATGCTGAGGTC-39; NV(74–111): 59-GCT-
AGCATGGAGGGGCATCTACTTTTT-39,5 9-GGATCCAA-
TCTGGGATAAGCAAGAAA-39; NV(1–20): 59-GCTAGCAT-
GGACCACCGCGAAACAAAC-39,5 9-GGATCCTTGTATCG-
CAGAACTTC-39; NV(21–35): 59- CTAGCATGAACGAGG-
TGGCCGGACACGGCTTCCTCTTTAAGGAGGGAGACC-
TGCCG-39,5 9-GATCCGGCAGGTCTCCCTCCTTAAAGA-
GGAAGCCGTGTCCGGCCACCTCGTTCATG-39; NV(DEGDL):
59-GCTAGCATGGACCACCGCGAAACAAAC-39,5 9-CACA-
CCATACCTTAAAGAGGAAGCCGTGTC-39,5 9-CCTCTTT-
AAGGTATGGTGTGAAGAGGACGA-39,5 9-GGATCCAAT-
CTGGGATAAGCAAGAAA-39. PCR products were inserted
into the NheI/BamHI site of pEGFP-N1.
To generate the plasmid constructs pEGFP/NV(31–35) and
pEGFP/NV(
32EGDL
35) and to mutate the
32EGDL
35 into
32AGDL
35,
32EADL
35,
32EGAL
35,o r
32EGDA
35, the following
oligonucleotides were synthesized at Integrated DNA Technolo-
gies (Coralville, IA), annealed, and ligated into the NheI/BamHI
site of pEGFP-N1 (CLONTECH, Inc.): NV(31–35): 59-CTAG-
CATGAAGGAGGGAGACCTGCCG-39,5 9-GATCCGGCAG-
GTCTCCCTCCTTCATG-39;
32EGDL
35:5 9-CTAGCATGGA-
GGGAGACCTGCCG-39,5 9-GATCCGGCAGGTCTCCCTC-
CATG-39;
32AGDL
35:5 9-CTAGCATGGCGGGAGACCTGCC
G-39,5 9-GATCCGGCAGGTCTCCCGCCATG-39;
32EADL
35:
59-CTAGCATGGAGGCAGACCTGCCG-39,5 9-GATCCGGC-
AGGTCTGCCTCCATG-39;
32EGAL
35:5 9-CTAGCATGGA-
GGGAGCCCTGCCG-39,5 9-GATCCGGCAGGGCTCCCTC-
CATG-39;
32EGDA
35:5 9-CTAGCATGGAGGGAGACGCGC-
CG-39,5 9-GATCCGGCGCGTCTCCCTCCATG-39.
To express the proteins in vitro, CHSE-214 and RTG-2 cells
were electroporated with various types of pEGFP/NV constructs
using the Neon
TM Transfection System (Invitrogen, Carlsbad, CA)
according to the manufacturer’s instructions.
Subcellular fractionation
Forty-eight hours after transfection with the pEGFP/NV(1–111)
constructs, CHSE-214 cells were harvested, and nuclear and
cytosolic fractions were prepared from 5610
7 CHSE-214 cells
using the Subcellular Proteome Extraction kit (ProteoExtract
TM,
Calbiochem, Darmstadt, Germany) according to the manufactur-
er’s instructions.
SDS-PAGE and Western blots
Cells were washed twice with cold PBS, and 30–50 mgo f
protein was resolved using SDS-PAGE, transferred onto Hybond-
P membranes (GE Healthcare, Piscataway, NJ), and probed with
appropriate dilutions of the anti-GFP (sc-9996, Santa Cruz
Biotechnology, Santa Cruz, CA) or anti-V5 antibody (Genentech,
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detection system (GE Healthcare). Autoradiography films were
exposed at multiple time points to ensure that the images were not
saturated.
Confocal microscopy
After transfection with 10 mg of various types of pEGFP/NV
constructs, cells were seeded on confocal dishes (SPL-200350, SPL
Life Sciences, Pocheon, Korea). On the following day, cells were
observed with a FluoView
TM 500 confocal microscope (Olympus,
Tokyo, Japan).
Viral growth analysis
Infections were carried out in 25 cm
2 culture flasks containing
confluent monolayers of RTG-2 cells at a MOI of 0.01 unless
otherwise stated. At the end of 1 h adsorption period at 16uC, the
cells were washed three times with MEM containing no serum.
Five milliliters of MEM containing 5% FBS was then added to
each culture flask and the flasks were incubated at 16uC. Samples
of 200 ml of medium were collected at 0, 24, and 48 h post-
infection (p.i.), and stored at 280uC. Viral titers were determined
for all samples, in duplicate, using a plaque assay on EPC cells as
described above.
Mx promoter-reporter assay
To confirm the presence and to quantify IFN in culture
supernatants, we used the transgenic RTG-P1 cell line that contains
a stable insertion of the IFN-responsive Mx promoter linked to a
luciferase reporter gene [36]. Culture supernatant samples were
collected from RTG-2 cells at 24 h p.i. and then incubated at 37uC
for 2 h to inactivate the virus. One milliliter of culture supernatant
sample was added to each of three wells in a 24-well plate
containing the transgenic RTG-P1 cells, and incubated for 48 h. As
a positive control, RTG-P1 cells were treated with poly I:C (25 mg/
ml) for 24 h. Cells from the wells were rinsed with EMEM-0 and
trypsinized. The detached cells were collected using centrifugation,
and the pellet was stored at 280uC. To assay the luciferase activity
cells were lysed with lysis buffer (Promega, Madison, WI) and mixed
with luciferase assay reagent (Promega) and the chemiluminescent
signal was measured in a Wallac Victor 1420 Multilabel Counter
(EG&G Wallac, Turku, Finland).
Plasmid construction and recovery of recombinant virus
A full-length antigenomic IHNV cDNA construct plasmid
(pIHNV) derived from a French IHNV strain (IHNV 32/87) [5]
was used to generate recombinant IHNVs (rIHNV). Coding
regions (ORFs) of wild-type NV and NV-DEGDL, in which the
nucleotides encoding
32EGDL
35 were deleted from the NV of the
IHNV-PRT strain, were amplified using RT-PCR from pEGFP/
NV(1–111) and pEGFP/NV(DEGDL), respectively. RT-PCR was
performed using the following primer pair: CACGTAAAGTAC-
CAGGTCATC, ACACACCCACAGTATCACT; Unique SpeI
and SmaI restriction enzyme sites surrounding the NV ORFs of
pIHNV were created by site-directed mutagenesis with the Quick
Change kit (Agilent Technologies, Inc., Santa Clara, CA). The
entire NV32/87 ORF of pIHNV was deleted using SpeI-SmaI
digestion and replaced with amplified DNA fragments containing
the NVPRT or NVPRT-DEGDL ORFs to generate pIHNV/
NVPRT or pIHNV/NVPRT(DEGDL), respectively. The presence
and positions of the inserted genes were confirmed by RT-PCR
and restriction enzyme analysis as well as sequencing of the
inserted sites in the plasmids. Recombinant viruses were recovered
from EPC cells as previously described [5]. To summarize briefly,
EPC cells were infected with a vaccinia virus recombinant that
expresses T7 RNA polymerase (vTF7-3) [39] and was transfected
with the full-length cDNA clones and three support plasmids that
expressed the N, P, and L proteins required for RNA encapsida-
tion and replication. Infectious viruses were recovered from the
supernatant medium, and were amplified by passage on EPC cells
at a low multiplication of infection. Viral titers of recombinant
virus stocks were quantified using the plaque assay. We also used
two additional rIHNVs as controls: a parental rIHNV generated
from a French IHNV strain (IHNV 32/87) and a rIHNV-DNV-
GFP in which the entire NV ORF was deleted and replaced with a
green fluorescent protein (GFP) ORF [5].
Quantitative real-time and semi-quantitative RT-PCR for
Mx1, IFN1 and IHNV G expressions in RTG-2 cells
Total RNA was isolated from infected cells using the Trizol
(Invitrogen) extraction method and DNase I-treated total RNA
was reverse transcribed using oligo-dT and Superscript II reverse
transcriptase (Invitrogen) according to the manufacturer’s instruc-
tions. Quantitative real-time PCR was performed using SYBRH
Green PCR Master Mix (Applied Biosystems, Foster City, CA)
and the ABI Prism 7900 HT (Applied Biosystems). Specificities of
each primer pair were confirmed via melting curve analysis and
agarose-gel electrophoresis. The housekeeping gene, acidic ribo-
somal phosphoprotein P0 (ARP) was used as a normalizing gene
[40], and PCR primer pairs were as follows: Mx1: 59-GG-
TTGTGCCATGCAACGTT-39,5 9-GGCTTGGTCAGGATG-
CCTAAT-39; IFN1: 59-GCGAAACAAACTGCTATTTACAA-
TGTATA-39,5 9-TCACAGCAATGACACACGCTC-39; IHNV-G:
59-GCGCACGCCGAGATAATATCAA-39,5 9-TCCCGTGAT-
AGATGGAGCCTTT-39; ARP: 59-GAAAATCATCCAATT-
GCTGGATG-39,5 9-CTTCCCACGCAAGGACAGA-39.
Statistical analysis
Differences in the expression of IFN1 and Mx1, as well as Mx1
promoter activity and the viral growth among rIHNVs-infected
cells, were evaluated by an unpaired Student’s t-test (two-tailed). A
P value,0.05 was considered to indicate statistical significance.
Results
Nuclear localization of NV-GFP
The NV of IHNV has been reported to be essential for efficient
growth and pathogenicity of IHNV [6]. In an effort to gain further
insight into the functions of the NV in viral replication, we first
examined the intracellular distribution of the NV. To date there is
no commercially available anti-IHNV NV antibody. Therefore,
we tagged the NV with GFP by cloning the full-length cDNA of
the NV gene into a pEGFP-N1 expression vector, transfected the
resulting plasmid [pEGFP/NV(1–111)] into CHSE-214 cells and
investigated the subcellular localization of the NV-GFP fusion
protein using confocal microscopy. Representative images of cells
transfected with plasmids encoding NV-GFP and GFP alone are
shown in Figure 1A. As expected, diffuse fluorescence was
observed throughout both the cytoplasm and the nucleus in the
pEGFP-N1-transfected cells (Figure 1A). However, fusion of the
NV protein to GFP altered the distribution of GFP, resulting in the
accumulation of fluorescent label in the nucleus and decreased
accumulation in the cytoplasm (Figure 1A).
To confirm the confocal microscopy observations, nuclear and
cytoplasmic fractions of CHSE-214 cells transfected with the
pEGFP-N1 and pEGFP/NV(1–111) plasmids were analyzed using
Western blot analysis with anti-GFP antibody (Figure 1B). The
presence of NV-GFP fusion protein in both the nuclear and
NLS of IHNV NV Is Necessary for IHNV Growth
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cellular distribution observed via fluorescence microscopy. The
GFP encoded by the control plasmid without fusion to NV was not
detected in the nuclei with Western blotting (Figure 1B). Although
the fluorescence signal of the GFP alone appeared evenly dis-
tributed throughout the cell, we suspect that the diffuse dis-
tribution in the cytoplasm made it appear that this protein was
distributed in the nucleus under fluorescence microscopy. These
results suggest that the nuclear localization of NV is an intrinsic
property of this protein and is independent of other viral factors.
The amino terminus of NV is required for nuclear
localization
The sequence of the NV gene does not encode any canonical
nuclear-localization signal (NLS) [41,42]. Thus to map the protein
domains responsible for nuclear localization, three NV fragments,
corresponding to amino acid residues (aa) 1 to 37 (NV(1–37)), aa
38 to 73 (NV(38–73)), and aa 74 to 111 (NV(74–111)) of NV, were
tagged with GFP (Figure 2A) and were expressed in CHSE-214
cells. Figure 2B shows typical images of cells that are represen-
tative of each truncated NV-GFP fusion protein at 48 h after
transfection. While both the NV(38–73) and the NV(74–111) were
evenly localized in the cytoplasm and the nucleus, the N-terminal
fragment NV(1–37) had a nuclear-localization pattern similar to
that of full-length NV(1–111) (Figure 2B), indicating that the
NV(1–37) alone can mediate nuclear targeting.
Amino acids
32EGDL
35 are responsible for nuclear
localization of NV protein
To more precisely define and characterize the regions within
the NV(1–37) responsible for nuclear localization, a series of
truncations from either the C or N terminus of NV(1–37) were
performed (Figure 3A). Each truncated NV fragment was tagged
with GFP and expressed in CHSE-214 cells. Removal of 31
additional residues from the N terminus or two residues from the
C terminus of NV(1–37) did not alter its nuclear localization pat-
tern (Figure 3B). Collectively, these results suggest that
32EGDL
35
of NV are sufficient for nuclear translocation since the
32EGDL
35-
GFP fusion protein accumulated in the nuclei (Figure 3B).
To determine whether
32EGDL
35 were essential for nuclear
localization of NV, they were deleted from the NV-GFP fusion
protein (Figure 3A). CHSE-214 cells were transfected with this
construct, and the distribution of the NV(D
32EGDL
35)-GFP
mutant proteins was examined 48 h after transfection. As shown
in Figure 3B, NV(D
32EGDL
35)-GFP was not targeted to the
nucleus, indicating that amino acid residues
32EGDL
35 are critical
for nuclear localization of NV.
To determine which amino acids within
32EGDL
35 are
necessary for nuclear localization, each amino acid within
32EGDL
35 was replaced with uncharged alanine and the resultant
mutants were expressed as fusion proteins with GFP (Figure 3A).
As shown in Figure 3B, all substitutions of amino acid residues
within the
32EGDL
35 decreased the accumulation of fluorescent
label in the nucleus (Figure 3B). These results suggest that all 4
residues within
32EGDL
35 may be critical for nuclear localization.
The nuclear localization of NV was also confirmed in RTG-2
cells using confocal microscopy. While fluorescent signals of the
NV-GFP and the
32EGDL
35-GFP were accumulated within the
nucleus, those of the NV(D
32EGDL
35)-GFP were diffused
throughout the nucleus and cytoplasm just like those of the GFP
(Figure 4). These results suggest that nuclear localization of IHNV
NV mediated by the amino acids
32EGDL
35 is common to both
CHSE-214 and RTG-2 cells.
Figure 1. Nuclear localization of NV-GFP proteins in CHSE-214
cells. CHSE-214 cells were transiently transfected with plasmids pEGFP-
N1 or pEGFP/NV(1–111) and incubated for 48 h. A, The fluorescent
signals were examined using confocal microscopy. Each image is
representative of the majority of the cells observed in several fields. B,
Cells were harvested and nuclear and cytoplasmic fractions were
prepared as described in the Materials and Methods section. The
resulting fractions were analyzed using 10% SDS-PAGE, followed by
Western blotting with anti-GFP antibody. C denotes the cytoplasmic
fraction, N denotes the nuclear fraction.
doi:10.1371/journal.pone.0022362.g001
Figure 2. Mapping of the NV region that supports nuclear localization. A, Schematic diagram of the full-length NV-GFP fusion protein and
truncated mutants containing the N-terminal (NV(1–37)), middle region (NV(38–73)), and C-terminal (NV(74–111)) of the NV protein. B, CHSE-214 cells
were transiently transfected with mutant NV constructs and examined live 48 h after transfection using confocal microscopy.
doi:10.1371/journal.pone.0022362.g002
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32EGDL
35 are required for the efficient
growth of IHNV in RTG-2 cells
To determine whether the amino acids
32EGDL
35 are involved
in the growth of IHNV in cell culture, two rIHNVs based on the
genomic background of rIHNV-32/87 were generated by
replacing the NV of rIHNV-32/87 strain with the wild-type NV
of the PRT strain (rIHNV-NVPRT) or mutant NV of PRT lacking
amino acids
32EGDL
35 (rIHNV-NVPRT-DEGDL) (Figure 5A). A
parental rIHNV-32/87 and a NV-knockout mutant rIHNV-32/
87-DNV-GFP [5] were used as controls.
The IHNV-PRT and IHNV-32/87 strains were originally
isolated from rainbow trout [5,37] and, thus, we examined growth
of the rIHNVs in rainbow trout-derived RTG-2 cells. We infected
RTG-2 cells with rIHNVs at an MOI of 0.01 and infectious virus
titers shed into the media were determined via plaque assay.
Figure 5B illustrates a comparison of the rIHNV yields at 0, 24,
and 48 h post-infection (p.i.) in RTG-2 cells, presented as averages
from three independent experiments. Replacement of the NV
gene of rIHNV-32/87 with the NV gene from the PRT strain of
IHNV did not result in any significant change in viral growth.
Deletion of the
32EGDL
35 resulted in a 9- and 5-fold decrease in
growth (9.8610
4 and 7.8610
5 PFU/ml) relative to rIHNV-
NVPRT (8.9610
5 and 3.9610
6 PFU/ml) at 24 and 48 h p.i.,
respectively. Deletion of the entire NV gene resulted in a 9- and
12-fold decrease in growth (9.8610
4 and 3.1610
5 PFU/ml)
relative to the parental rIHNV-32/87 (8.6610
5 and 3.86
10
6 PFU/ml) at 24 and 48 h p.i., respectively. To determine
whether expression of wild-type NV rescues the growth of NV-
knockout rIHNV, we analyzed the growth of rIHNVs in RTG-2
cells transfected with pcDNA3/NVPRT. As shown in Fig. 5C,
overexpression of NV significantly increased the viral yields of
rIHNV-32/87-DNV-GFP. These results demonstrate that NV is
essential for efficient growth of IHNV in RTG-2 cells and,
importantly, that the amino acid sequence
32EGDL
35 is critical for
the functioning of NV. However, deletion of the entire NV leads to
a greater decrease in viral growth than deletion of only the
32EGDL
35. After 72 h p.i., even though the viral yield of all four
rIHNVs increased, the difference in viral yield among the four
rIHNVs decreased and at 120 h p.i., all four rIHNVs yielded a
similar final infectivity titer (6.7,7.4 10
7 PFU/ml) (data not
shown). The reduced difference after 72 h p.i. was likely because
the RTG-2 cells infected with rIHNV-32/87 or rIHNV-NVPRT
were largely dead by 72 h p.i. while most cells infected with
rIHNV-32/87-DNV-GFP or rIHNV-NVPRT-DEGDL remained
alive.
NV is required for inhibition of poly I:C-induced IFN
responses in RTG-2 cells
Poly I:C is a well-documented inducer of IFN systems and viral
resistance in animal cells [43]. To determine the effects of a poly
I:C-induced IFN response on the growth of the rIHNVs, RTG-2
cells were treated with 25 mg/ml of poly I:C. As shown in the poly
I:C positive controls in Figure 6C and 6D, this treatment
significantly induced the expression of both IFN1 and the Mx1
gene in RTG-2 cells at 24 h after treatment. At 24 h after poly I:C
treatment cells were infected with rIHNV-32/87 or rIHNV-32/
87-DNV-GFP, samples of culture supernatant were collected at 0,
24, and 48 h p.i., and infectious titers were determined by plaque
Figure 3. Identification of an amino acid motif responsible for nuclear localization of NV. A, Schematic diagram of the GFP fusion proteins
used to identify the motif responsible for nuclear localization of NV. The names of the constructs are shown on the left. B, CHSE-214 cells were
transiently transfected with various types of plasmid constructs and, after incubation for 48 h, fluorescent signals were examined using confocal
microscopy. Each image is representative of the majority of the cells observed in several fields.
doi:10.1371/journal.pone.0022362.g003
Figure 4. Nuclear localization of NV-GFP protein in RTG-2 cells. A, Schematic diagram of the GFP fusion proteins used to transfect RTG-2 cells.
B, RTG-2 cells were transiently transfected with pEGFP-N1, pEGFP/NV(1–111), pEGFP/NV(
32EGDL
35), or pEGFP/NV(DEGDL). After incubation for 48 h,
fluorescent signals were examined using confocal microscopy. Each image is representative of the majority of the cells observed in several fields.
doi:10.1371/journal.pone.0022362.g004
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PLoS ONE | www.plosone.org 6 July 2011 | Volume 6 | Issue 7 | e22362assay. Poly I:C pre-treatment dramatically blocked the growth of
both rIHNV-32/87 and rIHNV-32/87-DNV-GFP (Figure 6A).
These results suggest that pre-existing antiviral responses induced
by poly I:C in RTG-2 cells can block the growth of IHNV even
with a functional NV.
Next, we determined whether poly I:C treatment after viral
infection can affect the growth of the IHNV. RTG-2 cells were
infected with rIHNV-32/87 or rIHNV-32/87-DNV-GFP and
then treated at 24 h p.i. with 25 mg/ml of poly I:C. The culture
supernatants were collected at 0 and 24 h after poly I:C treatment
and infectious titers were determined by plaque assay. As shown in
Figure 6B, while the growth of wild-type rIHNV-32/87 was not
significantly affected (1.2-fold), poly I:C treatment post-infection
induced a 13-fold decrease in the yield of the NV-knockout mutant
rIHNV-32/87-DNV-GFP. This suggests that wild type IHNV
may have mechanisms for overcoming the antiviral activity
Figure 5. Growths of rIHNV-32/87, rIHNV-32/87-DNV-GFP, rIHNV-NVPRT, and rIHNV-NVPRT-DEGDL in RTG-2 cells. A, Schematic
representation of the recombinant IHNVs used in this study. rIHNV-NVPRT, and rIHNV-NVPRT-DEGDL were generated as described in the Materials and
Methods section, and rIHNV-32/87 and rIHNV-32/87-DNV-GFP were used as controls. NVPRT refers to the NV gene from the IHNV PRT strain. All other
genes are from IHNV 32/87 strain. B, Comparative growths of rIHNV-32/87, rIHNV-32/87-DNV-GFP, rIHNV-NVPRT, or rIHNV-NVPRT-DEGDL in RTG-2 cells.
The cells were infected with rIHNVs at an MOI of 0.01 PFU/cell, and samples of the supernatant medium were collected at 0, 24, and 48 h p.i. The
samples were titrated in duplicate using a plaque assay on EPC cells. The results are presented as the means 6 SD of three independent experiments
(**P,0.01). C. Effect of NV expression on the growth of rIHNV-32/87-DNV-GFP in RTG-2 cells. RTG-2 cells were transfected with pcDNA6/V5-NVPRT or
empty vector pcDNA6/V5. After incubation for 24 h, the level of NV protein was determined by Western blotting with anti-V5 antibody (top panel).
RTG-2 cells transfected with pcDNA6/V5-NVPRT or empty vector were infected with rIHNVs at an MOI of 0.01 PFU/cell and samples of the supernatant
medium were collected at 0, 24, and 48 h p.i. The samples were titrated in duplicate using a plaque assay on EPC cells. The results are presented as
the means 6 SD of three independent experiments (**P,0.01).
doi:10.1371/journal.pone.0022362.g005
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PLoS ONE | www.plosone.org 7 July 2011 | Volume 6 | Issue 7 | e22362Figure 6. Requirement of NV for inhibition of poly I:C-induced IFN response in RTG-2 cells. A, Effect of poly I:C pre-treatment on the
growth of rIHNVs. RTG-2 cells were pre-incubated with poly I:C at 25 mg/ml for 24 h. The cells were then infected with rIHNV-32/87 or rIHNV-32/87-
DNV-GFP at an MOI of 0.01 PFU/cell and samples of the supernatant medium were collected at 0, 24, and 48 h p.i. All data points represent the
average of samples taken from duplicate infections. B, Effect of poly I:C treatment after virus infection on the growth of rIHNVs. RTG-2 cells were
infected with rIHNV-32/87 or rIHNV-32/87-DNV-GFP at an MOI of 0.01 PFU/cell. After incubation for 24 h, cells were washed three times and treated
with 25 mg/ml of poly I:C or serum-free media. At 0 and 24 h after poly I:C treatment, samples of the supernatant medium were collected and titrated
in duplicate. The virus titer in the supernatant medium collected at 0 h after poly I:C treatment was defined as one. The results are presented as the
means 6 SD of three independent experiments (***P,0.001). ns, not significant. C and D, Analysis of IFN1 and Mx1 expressions in RTG-2 cells treated
with poly I:C after virus infection. RTG-2 cells were infected with rIHNV-32/87 or rIHNV-32/87-DNV-GFP at an MOI of 1 PFU/cell. After incubation for
24 h, cells were incubated with culture media containing 25 mg/ml of poly I:C. At 24 h after poly I:C treatment, total RNA was extracted from the cells
and analyzed with real-time PCR for IFN1 (C) and Mx1 (D). The negative control was mock-infected RTG-2 cells without poly I:C treatment. The positive
control was mock-infected RTG-2 cells stimulated with 25 mg/ml poly I:C. The levels of IFN1 and Mx1 are expressed as mRNA copy number normalized
to 1000 copies of ARP mRNA. The results are presented as the means 6 SD of three independent experiments (**P,0.01; ***P,0.001).
doi:10.1371/journal.pone.0022362.g006
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PLoS ONE | www.plosone.org 8 July 2011 | Volume 6 | Issue 7 | e22362induced by poly I:C 24 h after IHNV infection, and that the NV
may be the key factor for this function.
To test if NV is involved in inhibition of the IFN response
induced by poly I:C, RTG-2 cells were infected with rIHNV-32/
87 or rIHNV-32/87-DNV-GFP and then treated at 24 h p.i. with
25 mg/ml of poly I:C. Cells were collected at 24 h after poly I:C
treatment and the expression levels of IFN1 and Mx1 were
determined using real-time PCR. Results were expressed as
mRNA copy number and normalized per 1000 copies of a
housekeeping gene mRNA (ARP). Cells infected with wild-type
rIHNV-32/87 or NV-knockout mutant rIHNV-32/87-DNV-GFP
produced decreased levels of IFN1 (12 and 19 copies, respectively)
and Mx1 (327 and 625 copies, respectively) compared with mock-
infected poly I:C treated control (IFN1, 31 copies; Mx1, 801
copies). However, cells infected with rIHNV-32/87-DNV-GFP
produced 1.4- and 1.8-fold higher amount of IFN1 and Mx1,
respectively, than those infected with rIHNV-32/87 (Figure 6C,
6D). This suggests that NV is required for effective inhibition of
poly I:C-induced IFN responses in RTG-2 cells, but virus without
NV is also capable of significant inhibition.
NV is required for the inhibition of the IHNV-induced IFN
response in RTG-2 cells
We also determined whether NV is involved in the blocking of
the IHNV-induced IFN system. RTG-2 cells were infected with
rIHNV-32/87 or rIHNV-32/87-DNV-GFP, after which total
RNA was extracted at 24 h p.i., and the induction of IFN1 was
analyzed using real-time RT-PCR. While wild-type rIHNV-32/87
induced a 1.5-fold increase in IFN1 expression (6 copies per 1000
copies of ARP mRNA) compared with mock-infected controls
(4 copies), the NV-knockout mutant rIHNV-32/87-DNV-GFP
induced a 6-fold increase in IFN1 expression (25 copies) (Figure
7A). If the NV is involved in the inhibition of IFN1 expression in
IHNV-infected cells, the NV-knockout mutant rIHNV should
induce higher levels of interferon-stimulated genes (ISGs) than the
wild-type rIHNV. To test this, we analyzed the expression level of
the Mx1 gene, one of the ISGs, in the rIHNV-infected RTG-2
cells using real-time PCR. While wild-type rIHNV-32/87 induced
a 6-fold increase in Mx1 gene expression (64 copies) relative to
mock infected controls (10 copies), the NV-knockout mutant
rIHNV-32/87-DNV-GFP induced a 48-fold increase of in Mx1
gene expression (478 copies) (Figure 7B). Taken together, these
data indicate that the NV may support the growth of IHNV
through inhibition of the IFN system in IHNV-infected RTG-2
cells.
In addition, we tested the effect of NV on the secretion of
functional IFN1 from IHNV-infected RTG-2 cells. Supernatants
were collected from RTG-2 cells infected with rIHNV-32/87 or
rIHNV-32/87-DNV-GFP at 24 h p.i. and IFN1 activities in the
supernatants were assayed using RTG-P1 cells. RTG-P1 cells are
RTG-2 derivatives stably transfected with a luciferase reporter
vector controlled by a rainbow trout Mx1 promoter [36]. RTG-P1
cells were treated with supernatants of RTG-2 cells for 48 h, cell
extracts were prepared and luciferase activity was measured.
RTG-P1 cells treated with supernatant from mock-infected RTG-
2 cells were used as a negative control and those treated with
25 mg/ml of poly I:C were used as a positive control. While the
supernatant of wild-type rIHNV-32/87-infected RTG-2 cells
showed a 1.1-fold increases in luciferase activity compared with
that of mock-infected RTG-2 cells, that of NV-knockout mutant
rIHNV-32/87-DNV-GFP induced a 2.5-fold increase in luciferase
activity (Figure 7C). This result is similar to the IFN1 gene
expression pattern obtained using real-time PCR (Figure 7A).
Together, these data revealed that the NV plays an important role
in the inhibition of IFN1 expression in IHNV-infected RTG-2
cells.
Figure 7. Requirement of NV for inhibition of IFN systems in IHNV-infected RTG-2 cells. A and B, IFN1 and Mx1 expression in RTG-2 cells
infected with rIHNV-32/87 or rIHNV-32/87-DNV-GFP. RTG-2 cells were harvested at 24 h p.i., and total RNA was analyzed with real-time PCR for IFN1
(A) and Mx1 (B). The negative control was mock-infected RTG-2 cells without poly I:C treatment. The positive control was mock-infected RTG-2 cells
stimulated with 25 mg/ml poly I:C. The levels of IFN1 and Mx1 are expressed as mRNA copy number normalized to 1000 copies of ARP mRNA. The
results are presented as the means 6 SD of three independent experiments (**P,0.01; ***P,0.001). C, Assay for functional IFN1 released from RTG-2
cells infected with rIHNV-32/87 or rIHNV-32/87-DNV-GFP. The culture supernatants were collected at 24 h p.i. and IFN activities were measured by
adding the supernatants to RTG-P1 cells and analyzing luciferase activity in RTG-P1 cells as described in the Materials and Methods. The negative
control was mock-infected RTG-2 cells without poly I:C treatment. The positive control was mock-infected RTG-2 cells stimulated with 25 mg/ml poly
I:C. The luciferase activity in the RTG-P1 cells treated with supernatants from the negative control cells was defined as one. The results are presented
as the means 6 SD of three independent experiments (*P,0.05; ***P,0.001).
doi:10.1371/journal.pone.0022362.g007
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32EGDL
35 are essential for the
anti-IFN activity of NV
Amino acids
32EGDL
35 within the NV were found to be
required for the efficient growth of IHNV in RTG-2 cells
(Figure 5B). Therefore, it is possible that this amino acid sequence
is essential for the ant-IFN activity of NV. We first determined
whether
32EGDL
35 are required for efficient growth of IHNV in
poly I:C-treated RTG-2 cells. In RTG-2 cells pre-treated with
25 mg/ml of poly I:C for 24 h, the growth of both rIHNV-NVPRT
and rIHNV-NVPRT-DEGDL were blocked (Figure 8A). However,
in RTG-2 cells treated with poly I:C at 24 h after viral infection,
the growth of wild-type rIHNV-NVPRT was not significantly
affected by poly I:C treatment, while that of rIHNV-NVPRT-
DEGDL was severely decreased (Figure 8B). Thus amino acids
32EGDL
35 are required for efficient growth of IHNV in RTG-2
cells treated with poly I:C after virus infection. We also determined
the expression levels of IFN1 and Mx1 in RTG-2 cells which were
infected with rIHNV-NVPRT or rIHNV-NVPRT-DEGDL and
then treated with 25 mg/ml of poly I:C at 24 h p.i. Cells infected
with rIHNV-NVPRT or rIHNV-NVPRT-DEGDL produced de-
creased levels of IFN1 (18 and 35 copies, respectively) and Mx1
(290 and 503 copies, respectively) compared with mock-infected
poly I:C treated control (IFN1, 53 copies; Mx1, 680 copies).
However, cells infected with rIHNV-NVPRT-DEGDL produced
1.9- and 1.7-fold higher amount of IFN1 and Mx1, respectively,
than those infected with rIHNV-NVPRT (Figure 8C, 8D).
To determine whether
32EGDL
35 are required to inhibit the
host IFN system, RTG-2 cells were infected with rIHNV-NVPRT
or rIHNV-NVPRT-DEGDL and the expression levels of IFN1 and
Mx1 were analyzed using real-time PCR at 24 h p.i. Their mRNA
copy numbers were normalized per 1000 copies of ARP mRNA.
While rIHNV-NVPRT induced 3- and 43-fold increases in IFN1 (9
copies) and Mx1 (295 copies) expressions compared with mock-
infected control (IFN1, 3 copies; Mx1, 7 copies), respectively,
rIHNV-NVPRT-DEGDL induced 9-fold and 73-fold increases of
IFN1 (26 copies) and Mx1 (515 copies) expressions, respectively
(Figure 8E, 8F). In addition, RTG-P1 cells treated with super-
natants from rIHNV-NVPRT-DEGDL-infected RTG-2 cells
showed 3.0-fold higher level of luciferase activity than those
treated with supernatants from rIHNV-NVPRT-infected RTG-2
cells (Figure 8G). Collectively, these data demonstrate that the
amino acid sequence
32EGDL
35 is essential for the efficient anti-
IFN activity of NV.
Discussion
NV is a non-virion protein whose gene is unique to the genus
Novirhabdovirus. Although NV is known to be required for the
efficient growth of IHNV in rainbow trout [6], the exact role of the
NV in IHNV infection is still unclear. In this study, we investigated
the cellular localization of NV by transient expression of a NV-
GFP fusion protein and showed that the NV protein can be
actively imported into the nucleus, since it can direct nuclear
accumulation of a cytoplasmic protein, GFP, in transiently
transfected CHSE-214 and RTG-2 cells. This demonstrates that,
even though it is smaller than the diffusion limits of the nuclear
pore complex (NPC), the 111-aa NV protein of IHNV is able to
exploit cellular mechanisms for active nuclear import. The region
of NV protein responsible for nuclear localization was mapped to
amino acid residues
32EGDL
35. A survey of IHNV NV sequences
present in GenBank revealed that these residues were conserved
among IHNV strains and especially amino acid residues
33GDL
35
were strictly conserved among all IHNV strains of which NV has
been sequenced (data not shown). We eliminated the possibility
that this short amino acid region comprises a portion of a larger
signal disrupted by removal of these amino acids, since the
addition of amino acids
32EGDL
35 to GFP resulted in the accu-
mulation of fluorescent label in the nucleus. To determine the role
of this motif in IHNV replication, we constructed a mutant
rIHNV expressing a
32EGDL
35-deleted NV protein (rIHNV-
NVPRT-DEGDL) and compared its growth in rainbow trout cells
with that of an NV-knockout mutant rIHNV (rIHNV-32/87-
DNV-GFP). Even though there was a slight difference in their
growth, the growth of both mutant rIHNVs was highly attenuated
in RTG-2 cells relative to rIHNV with an intact NV gene,
indicating that
32EGDL
35-mediated nuclear localization of NV is
important for NV function.
Importin b (karyopherin) proteins bind nuclear localization
signals (NLSs) to facilitate the nuclear import of NLS-containing
proteins [41]. Interestingly, amino acid sequence analysis revealed
that the IHNV NV does not contain any classical NLS. Therefore
it is necessary to consider the mechanism by which the NV protein
enters the nucleus. One possibility is that the amino acid sequence
32EGDL
35 is a novel NLS which can mediate the nuclear
transport of NV via binding to importins. Generally, NLSs which
bind either importin a or importin b have basic amino acid
residues such as lysine at their cores [41,44]. However,
32EGDL
35
do not contain any basic residues but, on the contrary, possess
acidic residues such as glutamic acid (E) and aspartic acid (D).
Thus, it is unlikely that
32EGDL
35 bind directly to importins.
Another possibility is that this motif mediates the nuclear import of
NV by binding to other proteins containing NLSs. Even though
the amino acid sequence
32EGDL
35 is highly conserved among
IHNV strains, it does not show any similarity to other known
motifs or domains. Thus, at present, it is difficult to predict
candidates for NLS-containing proteins to which
32EGDL
35 can
bind. Further characterization of the NV-interacting proteins,
including importins, will be needed to elucidate the molecular
mechanism through which the NV protein enters the nucleus.
Type I IFNs are well-known to block virus multiplication by
inducing upregulation of antiviral genes [8,9]. Recently, IFN genes
have been identified in a number of species of teleost fish including
rainbow trout [10]. Thus, IHNV should possess strategies to block
the induction of IFN systems in trout RTG-2 cells which would
otherwise suppress virus growth early in infection [7]. The
nonstructural proteins of RNA viruses have been reported to be
implicated in down-regulation of the host innate immune response
[7,45]. In this study, we provided evidences that the IHNV NV
possesses capability for down-regulation of the host IFN system: (a)
NV-knockout mutant rIHNV induced greater expressions of the
IFN1 and Mx1 genes than the wild-type rIHNV in RTG-2 cells;
(b) RTG-2 cells infected with NV-knockout rIHNV produced a
higher level of IFN1 activity in cell culture supernatant relative to
wild-type rIHNV; (c) wild-type rIHNV more efficiently blocked
the expressions of IFN1 and Mx1 than the NV-knockout mutant
rIHNV in RTG-2 cells treated with poly I:C after viral infection.
These results suggest that the NV protein can support IHNV
growth through inhibition of host IFN systems.
It is next necessary to determine the role of nuclear localization
of the NV as it pertains to its inhibitory function. IHNV is an RNA
virus that is believed to replicate in the cytoplasm like other RNA
viruses. Many RNA viruses whose primary site of replication is the
cytoplasm produce viral proteins that localize to the nucleus
during virus infection in order to inhibit IFN systems [46]. Thus, it
is possible to speculate that the IHNV NV protein localizes to the
nucleus to block the induction of IFN systems in RTG-2 cells. If
this is true, we would expect that the mutant rIHNV expressing an
32EGDL
35-deleted NV protein would less effectively block the IFN
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an
32EGDL
35-deleted NV induced more up-regulations of IFN1
and Mx1 gene expressions than the wild-type rIHNV in RTG-2
cells, and cells infected with this mutant produced a higher level of
IFN1 activity in cell culture supernatant relative to wild-type
rIHNV-infected cells. In addition, this mutant failed to block the
inductions of IFN1 and Mx1 in RTG-2 cells treated with poly I:C
after viral infection. The
32EGDL
35 deletion mutant mimicked the
NV knockout rIHNV in all experiments conducted here, sug-
gesting that the
32EGDL
35-mediated nuclear localization of NV is
critical for the inhibitory function of NV.
The existence of the NV gene is restricted only to the genus
Novirhabdovirus and, thus, it is likely that rhabdoviruses belonging to
genera other than the genus Novirhabdovirus use strategies different
from that of IHNV; the rhabdovirus vesicular stomatitis virus
(VSV) and rabies virus (RV) are good examples [24]. In the case of
VSV, the matrix (M) protein contains NLSs [31] and is reported to
suppress IFN systems through inhibition of the transcription factor
TFIID [25,26] and blocking of nuclear transport [29,30,35]. On
the contrary, RV uses phosphoprotein (P) to inhibit host IFN
systems [24]. The RV P protein contains an NLS [47] and
suppresses the IFN systems through inhibition of the nuclear
accumulation of STAT1, the binding of STAT1 to the DNA, and
the function of ISG products such as PML [34,48]. In this study,
we did not determine the subcellular localization of IHNV M and
P proteins and their potential functional roles in the inhibition of
host IFN systems. However, it is possible to speculate that IHNV
has evolved to use the NV protein instead of the M or P proteins to
inhibit the host IFN systems.
Among other species in the genus Novirhabdovirus there are
inconsistent reports regarding the importance of NV. For Viral
hemorrhagic septicemia virus (VHSV) recent reports demonstrate
that NV is required for efficient viral growth in cell culture and
pathogenicity in fish [49,50]. VHSV NV was reported to rescue
the growth of NV-knockout mutant rIHNV [6], suggesting the
possibility that VHSV NV supports the viral growth via inhi-
bition of host IFN system as IHNV NV does. However, the
underlying mechanisms of IFN inhibition of VHSV NV may be
different from those of IHNV NV, since VHSV NV exhibits a
low level of amino acid sequence similarity with IHNV NV
and does not have EGDL motif. It is unclear whether all
novirhabdoviruses use the NV to inhibit IFN systems, but if
they do, a different NLS may be utilized. In the case of a different
species, snakehead rhabdovirus (SHRV), an NV-knockout mu-
tant virus showed the same pathogenicity as wild-type virus,
suggesting that this virus may cope with the host antiviral
response using proteins other than NV [51]. Pathogenicity of
SHRV was tested using zebrafish instead of snakehead. Thus, it is
possible that the NV of SHRV might play an essential role for the
efficient growth and pathogenicity of the virus in the snakehead
fish host from which it originated.
Our data revealed that, in RTG-2 cells, poly I:C treatment
before viral infection induced high levels of IFN1 and Mx1 and
limited production of both wild-type and NV-knockout rIHNV.
However, when poly I:C treatment occurred after infection, this
treatment did not affect the growth of wild-type rIHNV but
significantly limited that of the NV-knockout rIHNV. This
suggests that, in RTG-2 cells treated with poly I:C after IHNV
infection, wild-type IHNV but not NV-knockout mutant IHNV
can cope with the IFN systems using the NV. However, in RTG-2
cells pre-treated with poly I:C, pre-existing antiviral activities may
block the expression of viral genes and, thus, it may be impossible
for IHNV to express a sufficiently large amount of NV protein
adequate to inhibit IFN systems.
In conclusion, our results show that the NV protein localizes to
the nucleus, and that the amino acid sequence
32EGDL
35 within
the NV protein is responsible for nuclear localization. Even though
the NV protein cannot cope with a pre-existing strong IFN
response, it has the capability to inhibit IFN1 synthesis and
32EGDL
35 are essential for this inhibitory activity. It remains
unclear as to how
32EGDL
35 mediate the nuclear localization of
NV and how these residues inhibit IFN systems. It will be
interesting to know which cellular proteins recognize these residues
of the NV protein to mediate nuclear localization of NV and to
inhibit IFN systems.
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Figure 8. The amino acids
32EGDL
35 are essential for the IFN1 inhibitory function of NV. A, Effects of poly I:C pre-treatment on the growth
of rIHNV-NVPRT and rIHNV-NVPRT-DEGDL in RTG-2 cells. RTG-2 cells were pre-incubated with poly I:C at 25 mg/ml for 24 h. Cells were then infected
with rIHNV-NVPRT or rIHNV-NVPRT-DEGDL at an MOI of 0.01 PFU/cell, and samples of the supernatant medium were collected at 0, 24, and 48 h p.i. All
data points represent the average titers of samples taken from duplicate infections. B, Effects of poly I:C treatment after viral infection on the growth
of rIHNV-NVPRT and rIHNV-NVPRT-DEGDL. RTG-2 cells were infected with rIHNV-NVPRT and rIHNV-NVPRT-DEGDL at an MOI of 0.01 PFU/cell. After
incubation for 24 h, cells were washed and incubated with fresh culture media containing 25 mg/ml of poly I:C. At 0 and 24 h after poly I:C treatment,
samples of the supernatant medium were collected. The virus titer in the supernatant medium collected at 0 h after poly I:C treatment was defined as
one. The results are presented as the means 6 SD of three independent experiments (**P,0.01). ns, not significant. C and D, Analysis of IFN1 and
Mx1 expressions in RTG-2 cells treated with poly I:C after viral infection. RTG-2 cells were infected with rIHNV-NVPRT, or rIHNV-NVPRT-DEGDL at an MOI
of 1 PFU/cell. After incubation for 24 h, cells were incubated with culture media containing 25 mg/ml of poly I:C. At 24 h after poly I:C treatment, total
RNA was extracted from the cells and analyzed with real-time PCR for IFN1 (C) and Mx1 (D). The negative control was mock-infected RTG-2 cells
without poly I:C treatment. The positive control was mock-infected RTG-2 cells stimulated with 25 mg/ml poly I:C. The levels of IFN1 and Mx1 are
expressed as mRNA copy number normalized to 1000 copies of ARP mRNA. The results are presented as the means 6 SD of three independent
experiments (*P,0.05; **P,0.01; ***P,0.001). E and F, IFN1 and Mx1 expression in RTG-2 cells infected with rIHNV-NVPRT, or rIHNV-NVPRT-DEGDL.
RTG-2 cells were harvested at 24 h p.i., and the total RNA was analyzed with real-time PCR for IFN1 (E) and Mx1 (F). The negative control was mock-
infected RTG-2 cells without poly I:C treatment. The positive control was mock-infected RTG-2 cells stimulated with 25 mg/ml poly I:C. The levels of
IFN1 and Mx1 are expressed as mRNA copy number normalized to 1000 copies of ARP mRNA. The results are presented as the means 6 SD of three
independent experiments (**P,0.01; ***P,0.001). G, Assay for functional IFN1 released from RTG-2 cells infected with rIHNV-NVPRT, or rIHNV-NVPRT-
DEGDL. The culture supernatants were collected from RTG-2 cells infected with rIHNV-NVPRT, or rIHNV-NVPRT-DEGDL at 24 h p.i. The IFN1 activities in
the supernatants were measured as described in the legend of Figure 7C. The negative control was mock-infected RTG-2 cells without poly I:C
treatment. The positive control was mock-infected RTG-2 cells stimulated with 25 mg/ml poly I:C. The luciferase activity in the RTG-P1 cells treated
with supernatants from the negative control cells was defined as one. The results are presented as the means 6 SD of three independent
experiments (***P,0.001).
doi:10.1371/journal.pone.0022362.g008
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